Abstract
A method of using an osteocrin (Ostn) or a NPR-C specific Ostn peptide derivative for increasing osteogenesis in a mammal comprising administering a therapeutically effective amount of said Ostn or NPR-C specific Ostn peptide derivative to the mammal.
Original language | Undefined/Unknown |
---|---|
Patent number | US7470668 B2 |
Priority date | 23/08/05 |
Publication status | Published - 30 Dec 2008 |